Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Poster
  • Published:

907 Pharmacokinetic Analysis Supports a Five Monthly Dose Schedule for Palivizumab

Pediatric Research volume 68, page 454 (2010)Cite this article

Download PDF

Author information

Authors and Affiliations

  1. Global Pharmaceutical Research and Development, Abbott, Abbott Park, IL, USA

    S K Paulson, G F Notario & W Awni

  2. Medlmmune, LLC, Gaithersburg, MD, USA

    L Zhao, L Roskos & G Robbie

  3. Global Pharmaceutical Research and Development, Abbott, Ludwigshafen, Germany

    P A Noertersheuser

Authors
  1. S K Paulson
    View author publications

    Search author on:PubMed Google Scholar

  2. L Zhao
    View author publications

    Search author on:PubMed Google Scholar

  3. P A Noertersheuser
    View author publications

    Search author on:PubMed Google Scholar

  4. G F Notario
    View author publications

    Search author on:PubMed Google Scholar

  5. W Awni
    View author publications

    Search author on:PubMed Google Scholar

  6. L Roskos
    View author publications

    Search author on:PubMed Google Scholar

  7. G Robbie
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Paulson, S., Zhao, L., Noertersheuser, P. et al. 907 Pharmacokinetic Analysis Supports a Five Monthly Dose Schedule for Palivizumab. Pediatr Res 68 (Suppl 1), 454 (2010). https://doi.org/10.1203/00006450-201011001-00907

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1203/00006450-201011001-00907

Search

Advanced search

Quick links